PsA: Treatment in Practice

Moderator(s)

• 

  M. Elaine Husni, MD, MPH

  Cleveland Clinic

Speaker(s)

• 

  Arthur Kavanaugh, MD

  UCSD
• 

  Jessica Walsh, MD

  Salt Lake City Veteran Affairs and University of Utah Medical Centers
• 

  Joel Gelfand, MD, MS

  University of Pennsylvania Perelman School of Medicine

As the number of therapeutic options expand for patients with psoriatic arthritis (PsA), rheumatology providers are challenged with absorbing an escalating volume of clinical trial data. Moreover, the complexity and heterogeneity of PsA require clinicians to personalize treatment options based on a solid comprehension of the different mechanism of actions of these targeted therapies. Recently, the addition of head to head trials in PsA have provided novel insights that are informative to the practitioner. Studies on patient-reported outcomes provide essential information that impact patient response and satisfaction but more work is needed to integrate PROs into routine decision making for our PsA patients. More rheumatology clinicians are involved in co-management with dermatology than ever before. At this session, faculty will review clinical trial translations of novel targeted therapies, share patient-reported outcomes data, and update co-management strategies between rheumatologists and dermatologists. In particular, the session will address the challenges of managing psoriatic arthritis in an individual patient and provide expert insights regarding therapeutic strategies for the individual, or "patients like me."

Learning Objectives:

• Evaluate available treatments and emerging therapeutic strategies for patients with PsA with a focus on head-to-head clinical trial data
• Formulate appropriate evaluation and management strategies using patient-reported outcomes and discuss the clinical translation of PROs in routine decision making
• Describe co-management strategies of patients with PsA and psoriasis in a rheumatologist/dermatologist setting

Presentations:

• 4:00 PM – 4:15 PM ET

  Psoriatic Arthritis Clinical Trials Update
  Arthur Kavanaugh, MD – UCSD
• 4:15 PM – 4:30 PM ET

  The Pros and Cons of Patient-Reported Outcomes
  Jessica Walsh, MD – Salt Lake City Veteran Affairs and University of Utah Medical Centers
• 4:30 PM – 4:45 PM ET

  Dermatologists and Rheumatologists Co-Managing Psoriatic Arthritis
  Joel Gelfand, MD, MS – University of Pennsylvania Perelman School of Medicine
• 4:45 PM – 5:00 PM ET

  Q&A